Page last updated: 2024-08-22

n-methylaspartate and tat-nr2b9c

n-methylaspartate has been researched along with tat-nr2b9c in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, J; Gladding, CM; Kaufman, AM; Milnerwood, AJ; Raymond, LA; Wang, L; Zhang, LY1

Other Studies

1 other study(ies) available for n-methylaspartate and tat-nr2b9c

ArticleYear
P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
    Neurobiology of disease, 2012, Volume: 45, Issue:3

    Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Bacterial Proteins; Cerebral Cortex; Chromosomes, Artificial, Yeast; Coculture Techniques; Corpus Striatum; Disease Models, Animal; Disks Large Homolog 4 Protein; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Guanylate Kinases; Humans; Huntingtin Protein; Huntington Disease; Immunoprecipitation; In Situ Nick-End Labeling; Luminescent Proteins; Membrane Proteins; Mice; Mice, Transgenic; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Peptides; Receptors, N-Methyl-D-Aspartate; Subcellular Fractions

2012